TITLE

Incidence of manifest glaucoma

AUTHOR(S)
Bengtsson, B O
PUB. DATE
July 1989
SOURCE
British Journal of Ophthalmology;Jul1989, Vol. 73 Issue 7, p483
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66032500

 

Related Articles

  • Web site explains angle-closure, glaucoma in children. Ritch, Robert // Ophthalmology Times;03/15/99, Vol. 24 Issue 6, p12 

    Part IV. Presents medical facts about glaucoma. Discussion on angle-closure glaucoma; Incidence of glaucoma in children; Ocular manifestations of Sturge-Weber syndrome.

  • Clinical setting may not reflect phase III glaucoma trials. Scerra, Chet // Ophthalmology Times;9/15/2002, Vol. 27 Issue 18, p32 

    Examines the factors affecting the effectiveness of anti-glaucoma medicines. Clinical manifestations of glaucoma; Types of medicines used to treat glaucoma; Comparison between latanoprost and brimonidine.

  • Ocular hypertension.  // British Medical Journal;5/13/1978, Vol. 1 Issue 6122, p1230 

    Examines the role of glaucoma in the development of blindness in Great Britain. Clinical manifestations of chronic simple glaucoma; Symptoms of chronic glaucoma; Enlargement of the optic cup.

  • Time to look again at sight tests. Wormald, Richard; Fraser, Scott // BMJ: British Medical Journal (International Edition);1/25/97, Vol. 314 Issue 7076, p245 

    Evaluates screening programs for glaucoma testing in Britain. Detecting presymptomatic chronic glaucoma; Survey on sight tests in Britain from 1990 to 1994; Incidence of glaucoma; Suggestions concerning glaucoma screening program.

  • EMGT Treatment and Progression Factors. Leske, M. Cristina // Review of Ophthalmology;Apr2003, Vol. 10 Issue 4, p102 

    Discusses factors related to glaucoma progression in Early Manifest Glaucoma Treatment study in the United States. Treatment effect; Progression findings; Predictors of progression.

  • Brain manifestations of glaucoma not to be overlooked. Guttman, Cheryl; Kaufman, Paul L. // Ophthalmology Times;04/15/2001, Vol. 26 Issue 8, p26 

    Discusses a research exploring the brain manifestations of glaucoma. Model used in the study; Findings on brain examination of the animals with experimentally induced glaucoma; Therapeutic implications of the findings.

  • Glaucoma Patients experience hyperemia with medications. Groves, Nancy // Ophthalmology Times;9/15/2002, Vol. 27 Issue 18, p27 

    Examines the effects of travopost and bimatoprost on the level of hyperemia in glaucoma patients. Clinical manifestations of glaucoma; Comparison between latanoprost and bimatoprost; Causes of hyperemia.

  • Glaucoma and the aging population in America. Kolker, Allan E. // Ophthalmology Times;12/1/2003 Supplement 6, Vol. 28, p14 

    Examines the prevalence of glaucoma in the aging population in America. Age and incidence of glaucoma; Risk consideration of blindness; Percentage rate of glacomatous damage at diagnosis.

  • Incidence of glaucoma said to be very high among blacks.  // New York Amsterdam News;1/7/95, Vol. 86 Issue 1, p30 

    Reports on the incidence of glaucoma among Afro-Americans. Risk factors; Diagnosis and treatment; Etiology; Occurrence; American Academy of Ophthalmology's study on glaucoma.

  • Thyroid-glaucoma connection revisited. Gordon, Richard N. // Ophthalmology Times;10/15/96, Vol. 21 Issue 26, p10 

    Discusses issues related to thyroid-glaucoma. Effect of thyroid orbitopathy on IOP; Treatments for thyroid; Clinical manifestations.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics